Efficacy and safety of ab interno excimer laser trabeculotomy in primary open-angle glaucoma: Two years of follow-up

Ab interno trabeculotomy was performed using the recently developed XeCl excimer laser in 21 eyes of 21 patients with primary open-angle glaucoma refractory to medical therapy. The patients were followed at the Eye Department of S. Antonio Hospital in Padova, for an average of 25.3 +/- 1.3 months. Intraocular pressure (IOP), visual acuity and ocular complications were evaluated. The laser procedure was quick and relatively easy, with minimal manipulation of tissues; complications were clinically insignificant. At the last follow-up, a marked IOP-lowering effect compared to baseline was observed (from 24.8 +/- 2.0 to 16.9 +/- 2.1 mm Hg; -31.8%, p < 0.0001). Nineteen patients (90.5%) had an IOP lowering of 20% or more; however, 8 of these eyes (38.1%) required additional IOP-lowering medical therapy. The procedure failed in 2 cases (9.5%) despite additional therapy. In conclusion ab interno excimer laser trabeculotomy seems effective to decrease IOP, serves to reduce the number of antiglaucoma medications and is relatively safe, proving to be a promising therapeutic option in glaucoma surgery. Copyright (c) 2006 S. Karger AG, Basel